Semaglutide and liraglutide are associated with reduced AUD and SUD-related hospitalization risks, unlike other GLP-1 ...

Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

Supplements promising similar results to Ozempic have taken over social media, but the TGA and health experts have concerns.

Find out which weight loss injections work best, how fast you can expect results, and whether combining them with other ...

Only 13 states currently allow Medicaid to cover GLP-1 agonist drugs for obesity treatment, highlighting a significant gap in ...

This drug operates primarily as a GLP-1 receptor agonist, which means it mimics the action of the glucagon-like peptide-1 hormone in the body. The GLP-1 hormone plays a vital role in regulating blood ...

Ω * The 12-week human clinical trial began in early June 2024 and set out to investigate if, through these mechanisms of action, the MindBody GLP-1 System could holistically and sustainably increase ...

the MindBody GLP-1 System could holistically and sustainably increase GLP-1 hormone levels in overweight adults, without unwanted side effects.* The study was conducted by independent researchers ...

the MindBody GLP-1 System could holistically and sustainably increase GLP-1 hormone levels in overweight adults, without unwanted side effects. The study was conducted by independent researchers ...